2009
DOI: 10.2174/187152009789056886
|View full text |Cite
|
Sign up to set email alerts
|

Tyrosinase Activated Melanoma Prodrugs

Abstract: Metastatic malignant melanoma remains a highly aggressive form of skin cancer for which no reliable methods for treatment exist. Given the increasing incidence of this cancer, considerable attention has focused on the development of new and improved methods for tackling this disease. Within this article, methods for treating melanoma are reviewed and discussed with particular attention focusing on prodrugs that are activated by the tyrosinase enzyme. This enzyme is up-regulated and is of elevated activity with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 39 publications
(22 citation statements)
references
References 0 publications
0
22
0
Order By: Relevance
“…Synthetic studies provide models of both complexes and evidence for rapid equilibrium between the two forms [3]. The monophenol hydroxylase and diphenoloxidase activities of tyrosinases are the basis for many industrial biotechnological applications like in environmental technology for the detoxification of phenol-containing waste waters and contaminated soils as a construction of a biosensor for the detaction of phenolic compound [4] and in pharmaceutical industries for the production of o -diphenols (e.g., L-DOPA, dopamine for the treatment of Parkinson's disease) and also have been tested as a marker in melanoma patients [5] and as a target for the activation of prodrugs [6] in food industries for modification of food proteins via crosslinking affects [7]. Synthetic melanin is also used for protection against radiation (UV, X-ray, and gamma ray), cation exchangers, drug carriers, antioxidants, antiviral agents, or immunogen.…”
Section: Introductionmentioning
confidence: 99%
“…Synthetic studies provide models of both complexes and evidence for rapid equilibrium between the two forms [3]. The monophenol hydroxylase and diphenoloxidase activities of tyrosinases are the basis for many industrial biotechnological applications like in environmental technology for the detoxification of phenol-containing waste waters and contaminated soils as a construction of a biosensor for the detaction of phenolic compound [4] and in pharmaceutical industries for the production of o -diphenols (e.g., L-DOPA, dopamine for the treatment of Parkinson's disease) and also have been tested as a marker in melanoma patients [5] and as a target for the activation of prodrugs [6] in food industries for modification of food proteins via crosslinking affects [7]. Synthetic melanin is also used for protection against radiation (UV, X-ray, and gamma ray), cation exchangers, drug carriers, antioxidants, antiviral agents, or immunogen.…”
Section: Introductionmentioning
confidence: 99%
“…Modification of dextranase with 1-ethyl-3-[3-(dimethylamino)-propyl]-carbodiimide and α-epoxyalkylα-glucosides caused inactivation of dextranase, indicating that carboxyl groups are essential for the enzyme action (15). High expression of tyrosinase to produce melanin in cancerous melanocytes can lead to an improvement in cancer, the same that can be controlled or treated by reducing or inhibiting the activity of tyrosinase (16). MT is a good model for such studies on structure-function relationship and also, it has a good potential for clinical, industrial, agricultural, and food studies.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, tyrosinases are associated with wound healing, with the immune response in plants [9, 10]. In humans, tyrosinase is involved in the pigmentation in melanocytes [1113], as a marker in melanoma patients [14] and as a target for the activation of prodrugs [15]. In the present work, as an initial step in evaluating the pharmaceutical potential of the tyrosinase of mushroom Agaricus bisporus , we undertook a preliminary characterization of the enzyme.…”
Section: Introductionmentioning
confidence: 99%